Search Results
Results found for "Addex Therapeutics"
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
accurately reflect native biological processes and preclinical research can more reliably translate into therapeutic Trends in clinical success rates and therapeutic focus. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Essential Frameworks for Precision Drug Discovery: An Insight into Advanced Strategies for Targeted Therapeutics
- 📰 GPCR Weekly News, January 8 to 14, 2024
MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic
- 📰 GPCR Weekly News, March 6 to 12, 2023
Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation
- From Failed Experiments to Predictive GPCR Models
increasingly depend on those who can unite modeling with experimentation, turning predictions into real therapeutic
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
GPCR dimers are therefore emerging drug targets in different therapeutic areas including depression,
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics
- 📰 GPCR Weekly News, December 18 to 31, 2023
Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics
- 📰 GPCR Weekly News, May 13 to 19, 2024
Mark your calendar for the GPCRs as Therapeutic Targets symposium on October 11th, 2024.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
continue to propel our quest to unravel the complexities of GPCR signaling and pave the way for novel therapeutic
- 📰 GPCR Weekly News, February 19 to 25, 2024
GPCR Binders, Drugs, and more Advances in structure-based drug design: The potential for precision therapeutics
- 📰 GPCR Weekly News
GPCRs in Neuroscience CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
crystal structures of both CBRs.[4–8] A key challenge in CBR modulator development is separating the therapeutic New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders.
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
have been approved as drugs, however they often have serious side effects and too low or temporary therapeutic Pharmacology & Therapeutics 2016 , 165 , 164–177. https://doi.org/10.1016/j.pharmthera.2016.06.007
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
This scavenging function should be considered when evaluating the safety and therapeutic efficacy of
- Decoding β-Arrestins: from Structure to function
within distinct cell types or tissues, will undoubtedly provide valuable guidance for advancing such therapeutic
- Structural landscape of the Chemokine Receptor system
binding and receptor activation will pave the way for significant advancements in the development of therapeutics
